Evidence map›Paper›PMID 31817833›Full record

ArticleCancers2019

Imaging and Tissue Biomarkers of Choline Metabolism in Diffuse Adult Glioma: 18F-Fluoromethylcholine PET/CT, Magnetic Resonance Spectroscopy, and Choline Kinase α.

Matthew Grech-Sollars, Katherine L Ordidge, Babar Vaqas, Claire Davies, Vijay Vaja, Lesley Honeyfield, Sophie Camp, David Towey, Helen Mayers, David Peterson and 4 more

Open access · goldAbstract read
In one paragraph

Article in Cancers, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.4field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 20 citations in OpenAlex.

  1. Metabolite ratiomics: Rapid diagnosis and classification of gliomas for intraoperative application during brain surgery.Proceedings of the National Academy of Sciences of the United States of America · 2026
    Article
  2. Article
  3. Review
  4. Review
  5. Bench to Bedside Development of [Molecules (Basel, Switzerland) · 2023
    Review
  6. Article
  7. Article
  8. Article
  9. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 5 institutions in 1 country.

Matthew Grech-SollarsDepartment of Surgery and Cancer, Imperial College London, London SW7 2AZ, UK.ORCID 0000-0003-3881-4870
Katherine L OrdidgeDepartment of Imaging, Imperial College Healthcare NHS Trust, London SW7 2AZ, UK.
Babar VaqasDepartment of Neurosurgery, Imperial College Healthcare NHS Trust, London SW7 2AZ, UK.
Claire DaviesDepartment of Surgery and Cancer, Imperial College London, London SW7 2AZ, UK.
Vijay VajaDepartment of Brain Sciences, Imperial College London, London SW7 2AZ, UK.
Lesley HoneyfieldDepartment of Imaging, Imperial College Healthcare NHS Trust, London SW7 2AZ, UK.
Sophie CampDepartment of Neurosurgery, Imperial College Healthcare NHS Trust, London SW7 2AZ, UK.
David ToweyNorthampton General Hospital NHS Trust, Northampton NN1 5BD, UK.ORCID 0000-0002-6209-3826
Helen MayersDepartment of Cellular Pathology, Salford Royal Foundation Trust, Salford M6 8HD, UK.
David PetersonDepartment of Neurosurgery, Imperial College Healthcare NHS Trust, London SW7 2AZ, UK.
Kevin O'NeillDepartment of Neurosurgery, Imperial College Healthcare NHS Trust, London SW7 2AZ, UK.
Federico RoncaroliDivision of Neuroscience and Experimental Psychology, University of Manchester, Manchester M13 9PL, UK.
Tara D BarwickDepartment of Surgery and Cancer, Imperial College London, London SW7 2AZ, UK.
Adam D WaldmanDepartment of Brain Sciences, Imperial College London, London SW7 2AZ, UK.
Imperial College Healthcare NHS Trust · GBImperial College London · GBNorthampton General Hospital NHS Trust · GBSalford Royal NHS Foundation Trust · GBUniversity of Manchester · GB

Funding

Brain Tumour Charity 33 / 159Brain Tumour Research Campaign N/ANational Institute for Health Research Imperial Biomedical Research Centre N/A
6 · The paper itself

Abstract

The cellular and molecular basis of choline uptake on PET imaging and MRS-visible choline-containing compounds is not well understood. Choline kinase alpha (ChoKα) is an enzyme that phosphorylates choline, an essential step in membrane synthesis. We investigate choline metabolism through 18F-fluoromethylcholine (18F-FMC) PET, MRS, and tissue ChoKα in human glioma. Fourteen patients with a suspected diffuse glioma underwent multimodal 3T MRI and dynamic 18F-FMC PET/CT prior to surgery. Co-registered PET and MRI data were used to target biopsies to regions of high and low choline signal, and immunohistochemistry for ChoKα expression was performed. The 18F-FMC/PET differentiated WHO (World Health Organization) grade IV from grade II and III tumours, whereas MRS differentiated grade III/IV from grade II tumours. Tumoural 18F-FMC/PET uptake was higher than in normal-appearing white matter across all grades and markedly elevated within regions of contrast enhancement. The 18F-FMC/PET correlated weakly with MRS Cho ratios. ChoKα expression on IHC was negative or weak in all but one glioblastoma sample, and did not correlate with tumour grade or imaging choline markers. MRS and 18F-FMC/PET provide complimentary information on glioma choline metabolism. Tracer uptake is, however, potentially confounded by blood-brain barrier permeability. ChoKα overexpression does not appear to be a common feature in diffuse glioma.

Indexed as

braincholinegliomaMRIPET

Identifiers

PMID31817833
PMCPMC6966628
OpenAlexW2993283808

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.